EUVIMEDOtkrijte EUVIMED
CrossrefInformacijska kartica

Thermal ablation versus surgical resection for ultrasound-detected solitary cT1N0M0 papillary thyroid carcinoma in elderly patients: a multicenter comparative study

Na Yu, Shengnan Huo, Songsong Wu, Zhibin Cong, Lihong Liu, Zhonghua Wang, Chunping Qu, Ying Wei, Zhenlong Zhao, Shiliang Cao, Jie Wu, Wenjia Cai, Meng Yang, Ming’an Yu

British Journal of Radiology · 2026-10-29

DOI: 10.1093/bjr/tqag242 ↗
SažetakBibliografski podaci

Sažetak

Abstract Objectives This study was aimed to compare the effectiveness and complication rates of thermal ablation (TA) vs surgical resection (SR) in managing ultrasound (US)-detected solitary T1N0M0 papillary thyroid carcinoma (PTC) in elderly patients, including those with occult lymph node metastasis (LNM). Methods This retrospective, multicenter study involved 225 elderly patients with solitary PTC who underwent TA or SR. Propensity score matching (PSM) was used to minimize confounding factors. After PSM, the SR group was divided into SR-T1N0 and SR-T1N1 subgroups based on postoperative lymph node pathology. Disease progression and complications were compared across groups. Results Seventy-eight patients underwent TA, and 147 underwent SR. No significant difference in disease progression was found (2.6% vs 1.4%; P = .860), including new tumors and LNM. After PSM, no differences were observed between groups (TA vs SR-T1N0/SR-T1N1) (P > .05). Major complications were similar, but permanent hoarseness and hypoparathyroidism occurred only in the SR group. The TA group had significantly fewer side effects (0% vs 25.9%, P < .001). Conclusions In elderly patients with US-detected solitary T1N0M0 PTC, disease progression was similar between TA and SR. However, TA better preserves thyroid function, making it a safer and effective treatment for this population. Advances in knowledge This study demonstrates that TA is as effective as SR in elderly patients with US-detected solitary T1N0M0 PTC, including those with occult LNM, while better preserving organ function. This makes it a viable option for patients unable or unwilling to undergo SR.

Znanje koje odgovara vašem radu.

Od besplatnog početka i osobnog pretraživanja literature do potpunog paketa Research Suite.

Prikaži tarife →

Jesu li uključeni svi cjeloviti tekstovi izdavača?

Ne. Bibliografski zapisi, sažeci i cjeloviti tekstovi različiti su sadržaji. Hoće li cjeloviti tekst biti dostupan ovisi o izvoru, Open Accessu i vašim postojećim licencama. Tarifa EUVIMED ne zamjenjuje dodatna izdavačka prava.

Prikaži tarife →